Latest filing published 08 Jul 2015 for Galectin Therapeutics INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +60.1%Entry US$3.11 · Close at T+365 US$4.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Herman Paul Pressler: trading record in brief
Herman Paul Pressler is a declared insider of Galectin Therapeutics Inc, with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 25 April 2012 to 8 April 2015.
The open-market record is one-sided, with 1 purchase worth €12k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants.
Most recently, on 8 July 2015, the filings show a share grant in Galectin Therapeutics Inc. The most recent open-market purchase was published on 26 April 2012, 5,310 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Herman Paul Pressler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,784 shares0Common StockSEC:0001179022-15-000088:0
- 25,483 shares0Common StockSEC:0001179022-15-000088:1
- 5,000 shares@ US$3.10Common StockSEC:0001181431-12-025885:0Canonical exit: 24 Jul 2012 (T+90)
3 of 3 declarations
